STOCK TITAN

Veeva Vault CRM Selected by Eli Lilly and Company

Veeva Systems (NYSE: VEEV) announced on August 11, 2026 that Eli Lilly and Company has committed to deploy Veeva Vault CRM globally.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Veeva Systems (NYSE: VEEV) announced on August 11, 2026 that Eli Lilly and Company has committed to deploy Veeva Vault CRM globally. Vault CRM is part of the Vault CRM Suite, which Veeva describes as the technology foundation for agentic commercial, a new AI-enabled commercial model to help bring the right medicines to more patients.

Executives from Lilly and Veeva highlighted the expansion of their strategic relationship as Lilly rolls out Vault CRM worldwide. Investors are directed to Veeva’s risk disclosures and forward-looking statement cautions in its Form 10-Q for the fiscal year ended April 30, 2026.

Loading...
Loading translation...
Argus Aug 11 session
+0.81% close to close Open Argus
Details

News Market Reaction – VEEV

On Aug 11, the day this news came out, VEEV closed 0.81% above the previous close.

Data tracked by StockTitan Argus for the Aug 11 session.

Key Figures

Announcement date: Aug. 11, 2026 Customers served: >1,500 customers
Announcement date
Aug. 11, 2026
Veeva announcement
Customers served
>1,500 customers
Veeva company description

Historical Context

5 past events · Latest: Aug 05
5 events
  1. Aug 05

    Earnings date notice

    24h Move
    +2.0%

    Scheduled fiscal 2027 second-quarter results and conference call for August 26

  2. Jun 25

    Application launch

    24h Move
    -2.0%

    Introduced Veeva EHS for operational risk management and intelligent automation

  3. Jun 23

    Acquisition and launch

    24h Move
    +4.3%

    Acquired Copli and launched Falcon MLR for content review

  4. Jun 09

    Customer platform adoption

    24h Move
    +0.3%

    UCB unified global pharmacovigilance operations on Veeva Safety Suite

  5. Jun 03

    Quarterly earnings report

    24h Move
    -0.1%

    Reported fiscal 2027 first-quarter revenue and updated full-year guidance

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

PLEASANTON, Calif., Aug. 11, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Eli Lilly and Company (Lilly) has committed to Veeva Vault CRM globally.

Veeva Vault CRM Selected by Eli Lilly and Company

Vault CRM is part of the Vault CRM Suite of applications that provides the technology foundation for agentic commercial, the new commercial model that leverages AI to get the right medicines to more patients.

"We are excited to expand our strategic work with Veeva by moving to Vault CRM," said Giuseppe Firenze, senior vice president, U.S. HCP and field engagement hub at Lilly. "Vault CRM will help Lilly bring our breakthrough medicines to more patients."

"Lilly creates medicines that make life better for people around the world," said Veeva CEO Peter Gassner. "We are proud to expand our strategic work with Lilly as they roll out Vault CRM globally."

Learn more about Veeva Vault CRM Suite, including the Agentic Call Report to generate Commercial Evidence, at veeva.com/crm.

About Veeva Systems
Veeva delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended April 30, 2026, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.

Contact:


Maria Scurry
Veeva Systems
maria.scurry@veeva.com

Meera Lakhani-Patel
Veeva Systems, Europe
meera.lakhani-patel@veeva.com

Veeva Systems

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-vault-crm-selected-by-eli-lilly-and-company-302847385.html

SOURCE Veeva Systems

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Eli Lilly decide regarding Veeva Vault CRM on August 11, 2026 (VEEV)?

Eli Lilly committed to deploy Veeva Vault CRM globally across its organization. According to Veeva, Vault CRM is part of the Vault CRM Suite and underpins an AI-driven commercial model aimed at helping get appropriate medicines to more patients worldwide.

What is Veeva Vault CRM Suite mentioned in the VEEV and Eli Lilly announcement?

Veeva Vault CRM Suite is a set of applications providing the technology foundation for agentic commercial. According to Veeva, it combines CRM capabilities with AI-driven tools, including features like the Agentic Call Report, to support evidence-based commercial engagement for life sciences companies.

How does Veeva describe the role of Vault CRM in Eli Lilly’s commercial model?

Veeva describes Vault CRM as enabling agentic commercial, a new AI-supported commercial approach. According to Veeva, this model is intended to help companies like Eli Lilly deliver the right medicines to more patients by enhancing field engagement and commercial decision-making.

Why is the Eli Lilly selection of Veeva Vault CRM important for Veeva Systems (VEEV)?

Eli Lilly’s global commitment expands Veeva’s strategic work with a major pharmaceutical customer. According to Veeva, the rollout of Vault CRM globally at Lilly reinforces Veeva’s role as a key industry cloud provider for large life sciences companies adopting AI-enabled commercial technology.

Keep reading